Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$153.03M
Total Bought:
$33.58M
Total Sold:
$23.17M
Net Transaction:
+$10.41M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Guardant Health, Inc.(GH)67,50067,5000$10.13M$12.04M7.87%+$1.91M
TG Therapeutics, Inc.(TGTX)164,915187,671+22,756$9.06M$10.47M6.84%+$1.41M
ABIVAX Société AnonymeADS(ABVX)46,87890,919+44,041$6.25M$9.00M5.88%+$2.76M
Praxis Precision Medicines, Inc.(PRAX)27,20529,681+2,476$9.11M$8.64M5.65%-$464.0K
Cogent Biosciences, Inc.(COGT)210,523210,5230$8.15M$6.74M4.41%-$1.41M
Eli Lilly and Company(LLY)5,4925,4920$6.59M$6.35M4.15%-$232.6K
Natera, Inc.(NTRA)13,80013,8000$3.75M$5.70M3.73%+$1.96M
Vera Therapeutics, Inc.CL A(VERA)97,276159,556+62,280$4.17M$5.15M3.37%+$978.0K
Viking Therapeutics, Inc.(VKTX)47,861147,497+99,636$1.87M$4.81M3.14%+$2.94M
Ionis Pharmaceuticals, Inc.(IONS)88,177107,034+18,857$6.99M$4.78M3.12%-$2.21M
Enliven Therapeutics Inc100,203100,2030$5.09M$4.59M3.00%-$492.0K
Caris Life Sciences, Inc.(CAI)78,180146,093+67,913$1.39M$4.47M2.92%+$3.08M
Nektar Therapeutics(NKTR)22,41773,708+51,291$1.56M$4.46M2.92%+$2.90M
Cytokinetics, Incorporated(CYTK)60,05660,0560$5.12M$3.96M2.59%-$1.16M
Verastem, Inc.(VSTM)429,041429,0410$1.64M$3.45M2.26%+$1.81M
Maze Therapeutics, Inc.(MAZE)114,692114,6920$3.42M$3.12M2.04%-$305.1K
Rhythm Pharmaceuticals, Inc.(RYTM)32,20932,2090$3.58M$3.07M2.00%-$509.4K
10x Genomics, Inc.CL A(TXG)102,62930,074-72,555$3.93M$2.72M1.78%-$1.22M
Alkermes plcSHS(ALKS)61,33661,3360$3.21M$2.49M1.62%-$728.4K
United Therapeutics Corporation(UTHR)5,4104,109-1,301$2.93M$2.23M1.46%-$704.7K
Boston Scientific Corporation(BSX)48,34748,3470$2.06M$2.11M1.38%+$46.9K
Arrowhead Pharmaceuticals, Inc.(ARWR)32,21432,2140$2.63M$2.11M1.38%-$517.4K
UnitedHealth Group Incorporated(UNH)9,6125,697-3,915$4.00M$2.09M1.37%-$1.90M
Ocular Therapeutix, Inc.(OCUL)181,588272,046+90,458$1.78M$2.09M1.36%+$303.4K
Alumis Inc204,418282,253+77,835$5.75M$2.09M1.36%-$3.67M
Penumbra, Inc.(PEN)6,3006,3000$1.99M$2.01M1.31%+$16.3K
Intuitive Surgical, Inc.(ISRG)4,9084,9080$1.95M$2.00M1.30%+$43.9K
MoonLake ImmunotherapeuticsCL A(MLTX)166,493166,4930$3.24M$1.95M1.27%-$1.29M
COMPASS Pathways plcADS(CMPS)0153,087+153,087$0$1.90M1.24%+$1.90M
Celldex Therapeutics, Inc.(CLDX)056,269+56,269$0$1.82M1.19%+$1.82M
Merck & Co., Inc.(MRK)012,358+12,358$0$1.80M1.17%+$1.80M
Liquidia Corporation(LQDA)39,22459,155+19,931$3.13M$1.79M1.17%-$1.34M
Glaukos Corporation(GKOS)19,86210,862-9,000$2.78M$1.78M1.17%-$992.5K
Monte Rosa Therapeutics Inc137,115137,015-100$3.32M$1.63M1.07%-$1.68M
BridgeBio Pharma, Inc.(BBIO)18,35921,209+2,850$1.37M$1.40M0.91%+$28.2K
Clearpoint Neuro Inc83,636110,174+26,538$1.49M$1.35M0.88%-$146.8K
Corbus Pharmaceuticals Hldgs184,914190,714+5,800$1.73M$1.30M0.85%-$433.8K
Cytomx Therapeutics Inc.460,067460,0670$1.73M$1.25M0.82%-$473.9K
Palvella Therapeutics, Inc.(PVLA)07,809+7,809$0$1.08M0.70%+$1.08M
Ascendis Pharma A/S(ASND)6,5734,414-2,159$1.75M$1.01M0.66%-$747.5K
Rapport Therapeutics, Inc.(RAPP)029,381+29,381$0$987.2K0.65%+$987.2K
Billiontoone IncCL A08,983+8,983$0$956.2K0.62%+$956.2K
Zenas BioPharma, Inc.(ZBIO)52,44334,341-18,102$1.33M$926.2K0.61%-$404.8K
Replimune Group, Inc.(REPL)40,36168,488+28,127$446.8K$906.8K0.59%+$460.0K
Equillium Inc552,956552,9560$1.77M$898.6K0.59%-$870.9K
Establishment Labs Holdings Inc.(ESTA)13,10013,1000$1.12M$840.6K0.55%-$283.5K
Climb Bio Inc071,215+71,215$0$816.8K0.53%+$816.8K
Novabridge BiosciencesADS576,960576,9600$1.13M$787.5K0.51%-$337.5K
Bright Minds Biosciences Inc10,11014,715+4,605$709.7K$733.1K0.48%+$23.4K
Compass Therapeutics Inc276,165511,084+234,919$604.8K$531.5K0.35%-$73.3K
Q32 Bio Inc062,589+62,589$0$517.6K0.34%+$517.6K
Capricor Therapeutics Inc051,531+51,531$0$488.0K0.32%+$488.0K
uniQure N.V.SHS(QURE)81,05618,300-62,756$3.73M$442.1K0.29%-$3.29M
Arbutus Biopharma Corp50,16650,1660$240.8K$239.8K0.16%-$1.0K
Adagene IncADS488,29352,543-435,750$2.05M$168.1K0.11%-$1.88M
Agios Pharmaceuticals, Inc.(AGIO)70,5000-70,500$2.62M$0—-$2.62M
AstraZeneca PLC(AZN)12,0450-12,045$2.25M$0—-$2.25M
Crescent Biopharma, Inc.(CBIO)127,7690-127,769$2.30M$0—-$2.30M
Geron Corporation(GERN)624,0460-624,046$798.8K$0—-$798.8K
Insmed Incorporated(INSM)13,8730-13,873$1.48M$0—-$1.48M
Relay Therapeutics, Inc.(RLAY)47,5310-47,531$889.3K$0—-$889.3K
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q3 2026 | TickerTrail